H.C. Wainwright Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $25
Express News | HC Wainwright & Co. Reiterates Buy on UniQure, Maintains $25 Price Target
Express News | UniQure Doses First Patient In Phase I/IIa Clinical Trial Of AMT-191 For Fabry Disease
UniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know
UniQure to Cut 65% of Workforce, or 300 Jobs, in Major Restructuring
Express News | Goldman Sachs Maintains Neutral on UniQure, Raises Price Target to $10
UniQure Analyst Ratings
RBC Capital Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $16
UniQure GAAP EPS of -$1.16, Revenue of $11.1M
A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $14 to $16
Express News | Uniqure NV : Mizuho Raises Target Price to $7 From $6
Express News | UniQure's Cash Position Of Approximately $524M As Of June 30, 2024, Expected To Fund Operations Through The End Of 2027
Express News | UniQure Q2 2024 GAAP EPS $(1.16), Inline, Sales $11.126M Beat $6.260M Estimate
uniQure NV | 10-Q: Q2 2024 Earnings Report
Earnings Flash (QURE) UNIQURE Posts Q2 Revenue $11.1M
UniQure: Runway To Fund Operations Through End 2027 >QURE
UniQure: Restructuring, Lexington Plant Sale to Cut Recurring Cash Burn by $75M/Year >QURE
UniQure Sets Organizational Restructuring Aimed at Streamlining Operations >QURE
Press Release: UniQure Announces Second Quarter 2024 Financial Results and Provides Company Update
UniQure 2Q Loss/Shr $1.16 >QURE